Shiga toxin interaction with human intestinal epithelium

Toxins

Volumn 3, Issue 6, 2011, Pages 626-639

  Schüller, Stephanie ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Human intestinal epithelium; Intracellular transport; Regulation; Shiga toxin; Translocation

Indexed keywords

GLOBOTRIAOSYLCERAMIDE; IRON; OXYGEN; SHIGA TOXIN; VEROTOXIN 1; VEROTOXIN 2;

BACTERIAL GENE; BACTERIAL VIRULENCE; CELL MIGRATION; CYTOTOXICITY; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE TRANSFER; HOST CELL; HOST PARASITE INTERACTION; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTRACELLULAR TRANSPORT; MEMBRANE VESICLE; NONHUMAN; REVIEW; SHIGA TOXIN 1 GENE; SHIGA TOXIN 2 GENE; TOXIN ANALYSIS; TOXIN SYNTHESIS; TRANSCRIPTION REGULATION; TRANSCYTOSIS;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIOPHAGES; BINDING SITES; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINAL MUCOSA; PROTEIN TRANSPORT; SHIGA TOXIN 1; SHIGA TOXIN 2; TRIHEXOSYLCERAMIDES;

BACTERIA (MICROORGANISMS);

EID: 79959653016     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins3060626     Document Type: Review

References (86)

1. Money, P.; Kelly, A.F.; Gould, S.W.; Denholm-Price, J.; Threlfall, E.J.; Fielder, M.D. Cattle, weather and water: Mapping Escherichia coli O157:H7 infections in humans in England and Scotland. Environ. Microbiol. 2010, 12, 2633-2644.
2. Tarr, P.I.; Gordon, C.A.; Chandler, W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005, 365, 1073-1086.
3. Karmali, M.A.; Petric, M.; Lim, C.; Fleming, P.C.; Arbus, G.S.; Lior, H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 1985, 151, 775-782.
4. Obrig, T.G.; Louise, C.B.; Lingwood, C.A.; Boyd, B.; Barley-Maloney, L.; Daniel, T.O. Endothelial heterogeneity in Shiga toxin receptors and responses. J. Biol. Chem. 1993, 268, 15484-15488.
5. Lindberg, A.A.; Brown, J.E.; Stromberg, N.; Westling-Ryd, M.; Schultz, J.E.; Karlsson, K.A. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J. Biol. Chem. 1987, 262, 1779-1785.
6. Strockbine, N.A.; Marques, L.R.; Newland, J.W.; Smith, H.W.; Holmes, R.K.; O'Brien, A.D. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect. Immunol. 1986, 53, 135-140.
7. Wagner, P.L.; Waldor, M.K. Bacteriophage control of bacterial virulence. Infect. Immunol. 2002, 70, 3985-3993.
8. Calderwood, S.B.; Mekalanos, J.J. Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. J. Bacteriol. 1987, 169, 4759-4764.
9. Ritchie, J.M.; Wagner, P.L.; Acheson, D.W.; Waldor, M.K. Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates. Appl. Environ. Microbiol. 2003, 69, 1059-1066.
10. Shimizu, T.; Ohta, Y.; Noda, M. Shiga toxin 2 is specifically released from bacterial cells by two different mechanisms. Infect. Immunol. 2009, 77, 2813-2823.
11. Wagner, P.L.; Livny, J.; Neely, M.N.; Acheson, D.W.; Friedman, D.I.; Waldor, M.K. Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol. Microbiol. 2002, 44, 957-970.
12. Wagner, P.L.; Neely, M.N.; Zhang, X.; Acheson, D.W.; Waldor, M.K.; Friedman, D.I. Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain. J. Bacteriol. 2001, 183, 2081-2085.
13. McGannon, C.M.; Fuller, C.A.; Weiss, A.A. Different classes of antibiotics differentially influence Shiga toxin production. Antimicrob. Agents Chemother. 2010, 54, 3790-3798.
14. Łoś, J.M.; Łoś, M.; Wegrzyn, G.; Wegrzyn, A. Differential efficiency of induction of various lambdoid prophages responsible for production of Shiga toxins in response to different induction agents. Microbiol. Pathog. 2009, 47, 289-298.
15. Mühldorfer, I.; Hacker, J.; Keusch, G.T.; Acheson, D.W.; Tschäpe, H.; Kane, A.V.; Ritter, A.; Ölschläger, T.; Donohue-Rolfe, A. Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect. Immunol. 1996, 64, 495-502.
16. Waldor, M.K.; Friedman, D.I. Phage regulatory circuits and virulence gene expression. Curr. Opin. Microbiol. 2005, 8, 459-465.
17. Shimizu, T.; Ohta, Y.; Tsutsuki, H.; Noda, M. Construction of a novel bioluminescent reporter system for investigating Shiga toxin expression of enterohemorrhagic Escherichia coli. Gene 2011, 478, 1-10.
18. Griffin, P.M.; Tauxe, R.V. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol. Rev. 1991, 13, 60-98.
19. Heuvelink, A.E.; van de Kar, N.C.; Meis, J.F.; Monnens, L.A.; Melchers, W.J. Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe. Epidemiol. Infect. 1995, 115, 1-14.
20. Amano, A.; Takeuchi, H.; Furuta, N. Outer membrane vesicles function as offensive weapons in host-parasite interactions. Microbes Infect. 2010, 12, 791-798.
21. Ellis, T.N.; Kuehn, M.J. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol. Mol. Biol. Rev. 2010, 74, 81-94.
22. Kolling, G.L.; Matthews, K.R. Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl. Environ. Microbiol. 1999, 65, 1843-1848.
23. Yokoyama, K.; Horii, T.; Yamashino, T.; Hashikawa, S.; Barua, S.; Hasegawa, T.; Watanabe, H.; Ohta, M. Production of Shiga toxin by Escherichia coli measured with reference to the membrane vesicle-associated toxins. FEMS Microbiol. Lett. 2000, 192, 139-144.
24. Kesty, N.C.; Mason, K.M.; Reedy, M.; Miller, S.E.; Kuehn, M.J. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J. 2004, 23, 4538-4549.
25. Marteyn, B.; Scorza, F.B.; Sansonetti, P.J.; Tang, C. Breathing life into pathogens: The influence of oxygen on bacterial virulence and host responses in the gastrointestinal tract. Cell. Microbiol. 2011, 13, 171-176.
26. James, B.W.; Keevil, C.W. Influence of oxygen availability on physiology, verocytotoxin expression and adherence of Escherichia coli O157. J. Appl. Microbiol. 1999, 86, 117-124.
27. Asahara, T.; Shimizu, K.; Nomoto, K.; Hamabata, T.; Ozawa, A.; Takeda, Y. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect. Immunol. 2004, 72, 2240-2247.
28. Carey, C.M.; Kostrzynska, M.; Ojha, S.; Thompson, S. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. J. Microbiol. Methods 2008, 73, 125-132.
29. De Sablet, T.; Chassard, C.; Bernalier-Donadille, A.; Vareille, M.; Gobert, A.P.; Martin, C. Human microbiota-secreted factors inhibit Shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7. Infect. Immunol. 2009, 77, 783-790.
30. Gamage, S.D.; Strasser, J.E.; Chalk, C.L.; Weiss, A.A. Nonpathogenic Escherichia coli can contribute to the production of Shiga Toxin. Infect. Immunol. 2003, 71, 3107-3115.
31. Vareille, M.; de Sablet, T.; Hindré, T.; Martin, C.; Gobert, A.P. Nitric oxide inhibits Shiga-toxin synthesis by enterohemorrhagic Escherichia coli. Proc. Natl. Acad. Sci. USA 2007, 104, 10199-10204.
32. Wagner, P.L.; Acheson, D.W.; Waldor, M.K. Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli. Infect. Immunol. 2001, 69, 1934-1937.
33. Phillips, A.D.; Navabpour, S.; Hicks, S.; Dougan, G.; Wallis, T.; Frankel, G. Enterohaemorrhagic Escherichia coli O157:H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine. Gut 2000, 47, 377-381.
34. Poirier, K.; Faucher, S.P.; Beland, M.; Brousseau, R.; Gannon, V.; Martin, C.; Harel, J.; Daigle, F. Escherichia coli O157:H7 survives within human macrophages: Global gene expression profile and involvement of the Shiga toxins. Infect. Immunol. 2008, 76, 4814-4822.
35. Jacewicz, M.S.; Mobassaleh, M.; Gross, S.K.; Balasubramanian, K.A.; Daniel, P.F.; Raghavan, S.; McCluer, R.H.; Keusch, G.T. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. J. Infect. Dis. 1994, 169, 538-546.
36. Waddell, T.; Cohen, A.; Lingwood, C.A. Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide. Proc. Natl. Acad. Sci. USA 1990, 87, 7898-7901.
37. Kovbasnjuk, O.; Edidin, M.; Donowitz, M. Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells. J. Cell Sci. 2001, 114, 4025-4031.
38. Falguières, T.; Mallard, F.; Baron, C.; Hanau, D.; Lingwood, C.; Goud, B.; Salamero, J.; Johannes, L. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell 2001, 12, 2453-2468.
39. Hanashima, T.; Miyake, M.; Yahiro, K.; Iwamaru, Y.; Ando, A.; Morinaga, N.; Noda, M. Effect of Gb3 in lipid rafts in resistance to Shiga-like toxin of mutant Vero cells. Microbiol. Pathog. 2008, 45, 124-133.
40. Kiarash, A.; Boyd, B.; Lingwood, C.A. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J. Biol. Chem. 1994, 269, 11138-11146.
41. Binnington, B.; Lingwood, D.; Nutikka, A.; Lingwood, C.A. Effect of globotriaosyl ceramide fatty acid alpha-hydroxylation on the binding by verotoxin 1 and verotoxin 2. Neurochem. Res. 2002, 27, 807-813.
42. Arab, S.; Lingwood, C.A. Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic. J. Cell. Physiol. 1998, 177, 646-660.
43. Fraser, M.E.; Fujinaga, M.; Cherney, M.M.; Melton-Celsa, A.R.; Twiddy, E.M.; O'Brien, A.D.; James, M.N. Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J. Biol. Chem. 2004, 279, 27511-27517.
44. Garred, O.; van Deurs, B.; Sandvig, K. Furin-induced cleavage and activation of Shiga toxin. J. Biol. Chem. 1995, 270, 10817-10821.
45. Sandvig, K.; Garred, O.; Prydz, K.; Kozlov, J.V.; Hansen, S.H.; van Deurs, B. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 1992, 358, 510-512.
46. Endo, Y.; Tsurugi, K.; Yutsudo, T.; Takeda, Y.; Ogasawara, T.; Igarashi, K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 1988, 171, 45-50.
47. Smith, W.E.; Kane, A.V.; Campbell, S.T.; Acheson, D.W.; Cochran, B.H.; Thorpe, C.M. Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells. Infect. Immunol. 2003, 71, 1497-1504.
48. Hoey, D.E.; Sharp, L.; Currie, C.; Lingwood, C.A.; Gally, D.L.; Smith, D.G. Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity. Cell. Microbiol. 2003, 5, 85-97.
49. Naylor, S.W.; Low, J.C.; Besser, T.E.; Mahajan, A.; Gunn, G.J.; Pearce, M.C.; McKendrick, I.J.; Smith, D.G.; Gally, D.L. Lymphoid follicle-dense mucosa at the terminal rectum is the principal site of colonization of enterohemorrhagic Escherichia coli O157:H7 in the bovine host. Infect. Immunol. 2003, 71, 1505-1512.
50. Pruimboom-Brees, I.M.; Morgan, T.W.; Ackermann, M.R.; Nystrom, E.D.; Samuel, J.E.; Cornick, N.A.; Moon, H.W. Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins. Proc. Natl. Acad. Sci. USA 2000, 97, 10325-10329.
51. Sandvig, K.; Ryd, M.; Garred, O.; Schweda, E.; Holm, P.K.; van Deurs, B. Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP. J. Cell Biol. 1994, 126, 53-64.
52. Björk, S.; Breimer, M.E.; Hansson, G.C.; Karlsson, K.A.; Leffler, H. Structures of blood group glycosphingolipids of human small intestine. A relation between the expression of fucolipids of epithelial cells and the ABO, Le and Se phenotype of the donor. J. Biol. Chem. 1987, 262, 6758-6765.
53. Holgersson, J.; Jovall, P.A.; Breimer, M.E. Glycosphingolipids of human large intestine: Detailed structural characterization with special reference to blood group compounds and bacterial receptor structures. J. Biochem. 1991, 110, 120-131.
54. Schüller, S.; Frankel, G.; Phillips, A.D. Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture. Cell. Microbiol. 2004, 6, 289-301.
55. Miyamoto, Y.; Iimura, M.; Kaper, J.B.; Torres, A.G.; Kagnoff, M.F. Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo. Cell. Microbiol. 2006, 8, 869-879.
56. Engedal, N.; Skotland, T.; Torgersen, M.L.; Sandvig, K. Shiga toxin and its use in targeted cancer therapy and imaging. Microbiol. Biotechnol. 2010, 4, 32-46.
57. Falguières, T.; Maak, M.; von Weyhern, C.; Sarr, M.; Sastre, X.; Poupon, M. F.; Robine, S.; Johannes, L.; Janssen, K.P. Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool. Mol. Cancer Ther. 2008, 7, 2498-2508.
58. Kovbasnjuk, O.; Mourtazina, R.; Baibakov, B.; Wang, T.; Elowsky, C.; Choti, M. A.; Kane, A.; Donowitz, M. The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc. Natl. Acad. Sci. USA 2005, 102, 19087-19092.
59. Jacewicz, M.S.; Acheson, D.W.; Mobassaleh, M.; Donohue-Rolfe, A.; Balasubramanian, K.A.; Keusch, G.T. Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells. J. Clin. Invest. 1995, 96, 1328-1335.
60. Zumbrun, S.D.; Hanson, L.; Sinclair, J.F.; Freedy, J.; Melton-Celsa, A.R.; Rodriguez-Canales, J.; Hanson, J.C.; O'Brien, A.D. Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide. Infect. Immunol. 2010, 78, 4488-4499.
61. Philpott, D.J.; Ackerley, C.A.; Kiliaan, A.J.; Karmali, M.A.; Perdue, M.H.; Sherman, P.M. Translocation of verotoxin-1 across T84 monolayers: Mechanism of bacterial toxin penetration of epithelium. Am. J. Physiol. 1997, 273, 1349-1358.
62. Tam, P.J.; Lingwood, C.A. Membrane cytosolic translocation of verotoxin A1 subunit in target cells. Microbiology 2007, 153, 2700-2710.
63. Laiko, M.; Murtazina, R.; Malyukova, I.; Zhu, C.; Boedeker, E.C.; Gutsal, O.; O'Malley, R.; Cole, R.N.; Tarr, P.I.; Murray, K.F. et al. Shiga toxin 1 interaction with enterocytes causes apical protein mistargeting through the depletion of intracellular galectin-3. Exp. Cell Res. 2010, 316, 657-666.
64. Schüller, S.; Heuschkel, R.; Torrente, F.; Kaper, J.B.; Phillips, A.D. Shiga toxin binding in normal and inflamed human intestinal mucosa. Microbes Infect. 2007, 9, 35-39.
65. Brigotti, M.; Tazzari, P.L.; Ravanelli, E.; Carnicelli, D.; Rocchi, L.; Arfilli, V.; Scavia, G.; Minelli, F.; Ricci, F.; Pagliaro, P. et al. Clinical Relevance of Shiga Toxin Concentrations in the Blood of Patients With Hemolytic Uremic Syndrome. Pediatr. Infect. Dis. J. 2011, 30, 486-490.
66. Imai, Y.; Fukui, T.; Kurohane, K.; Miyamoto, D.; Suzuki, Y.; Ishikawa, T.; Ono, Y.; Miyake, M. Restricted expression of Shiga toxin binding sites on mucosal epithelium of mouse distal colon. Infect. Immunol. 2003, 71, 985-990.
67. Mobassaleh, M.; Gross, S.K.; McCluer, R.H.; Donohue-Rolfe, A.; Keusch, G.T. Quantitation of the rabbit intestinal glycolipid receptor for Shiga toxin. Further evidence for the developmental regulation of globotriaosylceramide in microvillus membranes. Gastroenterol 1989, 97, 384-391.
68. Golan, L.; Gonen, E.; Yagel, S.; Rosenshine, I.; Shpigel, N.Y. Enterohemorrhagic Escherichia coli induce attaching and effacing lesions and hemorrhagic colitis in human and bovine intestinal xenograft models. Dis. Models Mech. 2011, 4, 86-94.
69. Shigeno, T.; Akamatsu, T.; Fujimori, K.; Nakatsuji, Y.; Nagata, A. The clinical significance of colonoscopy in hemorrhagic colitis due to enterohemorrhagic Escherichia coli O157:H7 infection. Endoscopy 2002, 34, 311-314.
70. Acheson, D.W.; Moore, R.; De Breucker, S.; Lincicome, L.; Jacewicz, M.; Skutelsky, E.; Keusch, G.T. Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infect. Immunol. 1996, 64, 3294-3300.
71. Hurley, B.P.; Jacewicz, M.; Thorpe, C.M.; Lincicome, L.L.; King, A.J.; Keusch, G.T.; Acheson, D.W. Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells. Infect. Immunol. 1999, 67, 6670-6677.
72. Hurley, B.P.; Thorpe, C.M.; Acheson, D.W. Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect. Immunol. 2001, 69, 6148-6155.
73. Maluykova, I.; Gutsal, O.; Laiko, M.; Kane, A.; Donowitz, M.; Kovbasnjuk, O. Latrunculin B facilitates Shiga toxin 1 transcellular transcytosis across T84 intestinal epithelial cells. Biochim. Biophys. Acta 2008, 1782, 370-377.
74. Malyukova, I.; Murray, K.F.; Zhu, C.; Boedeker, E.; Kane, A.; Patterson, K.; Peterson, J.R.; Donowitz, M.; Kovbasnjuk, O. Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296, G78-G92.
75. Viswanathan, V.K.; Koutsouris, A.; Lukic, S.; Pilkinton, M.; Simonovic, I.; Simonovic, M.; Hecht, G. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function. Infect. Immunol. 2004, 72, 3218-3227.
76. Philpott, D.J.; McKay, D.M.; Mak, W.; Perdue, M.H.; Sherman, P.M. Signal transduction pathways involved in enterohemorrhagic Escherichia coli-induced alterations in T84 epithelial permeability. Infect. Immunol. 1998, 66, 1680-1687.
77. Klein, E.J.; Stapp, J.R.; Clausen, C.R.; Boster, D.R.; Wells, J.G.; Qin, X.; Swerdlow, D.L.; Tarr, P.I. Shiga toxin-producing Escherichia coli in children with diarrhea: A prospective point-of-care study. J. Pediatr. 2002, 141, 172-177.
78. Slutsker, L.; Ries, A.A.; Greene, K.D.; Wells, J.G.; Hutwagner, L.; Griffin, P.M. Escherichia coli O157:H7 diarrhea in the United States: Clinical and epidemiologic features. Ann. Intern. Med. 1997, 126, 505-513.
79. Griffin, P.M.; Olmstead, L.C.; Petras, R.E. Escherichia coli 0157:H7-associated colitis. A clinical and histological study of 11 cases. Gastroenterol 1990, 99, 142-149.
80. Moon, H.W. Comparative histopathology of intestinal infections. Adv. Exp. Med. Biol. 1997, 412, 1-19.
81. van de Kar, N.C.; Monnens, L.A.; Karmali, M.A.; van Hinsbergh, V.W. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: Implications for the pathogenesis of the hemolytic uremic syndrome. Blood 1992, 80, 2755-2764.
82. Keusch, G.T.; Acheson, D.W.; Aaldering, L.; Erban, J.; Jacewicz, M.S. Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells. J. Infect. Dis. 1996, 173, 1164-1170.
83. Louise, C.B.; Kaye, S.A.; Boyd, B.; Lingwood, C.A.; Obrig, T.G. Shiga toxin-associated hemolytic uremic syndrome: Effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin. Infect. Immunol. 1995, 63, 2766-2769.
84. Ohmi, K.; Kiyokawa, N.; Takeda, T.; Fujimoto, J. Human microvascular endothelial cells are strongly sensitive to Shiga toxins. Biochem. Biophys. Res. Commun. 1998, 251, 137-141.
85. Sansonetti, P.J.; Phalipon, A.M cells as ports of entry for enteroinvasive pathogens: Mechanisms of interaction, consequences for the disease process. Semin. Immunol. 1999, 11, 193-203.
86. Maresca, M.; Dumay, E.; Fantini, J.; Caporiccio, B. Selective transport of staphylococcal enterotoxin A through in vitro generated human M cells. Microbes Infect. 2007, 9, 1507-1510.